findmyKOL
Clinical trialNCT03028350CompletedPhase 2Interventional

Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)

SponsorCumberland PharmaceuticalsEnrollment54Asthma, Aspirin-Induced
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Banner University of Arizona Medical Center, Asthma & Airway Disease Research Center

    Tucson, Arizona, United States

  • Antelope Valley Clinical Trials

    Lancaster, California, United States

  • Scripps Clinic - Carmel Valley

    San Diego, California, United States

  • Stanford University Medical Center

    Stanford, California, United States

  • the Research Center

    Hialeah, Florida, United States

  • Emory University School of Medicine, Sinus, Nasal, and Allergy Center

    Atlanta, Georgia, United States

  • Deaconess Clinic

    Evansville, Indiana, United States

  • Kansas City Allergy and Asthma Associates, Pa

    Overland Park, Kansas, United States

  • Advanced Ent & Allergy

    Louisville, Kentucky, United States

  • Rochester Regional Health

    Rochester, New York, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Wake Forest Baptist Health

    Winston-Salem, North Carolina, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

  • Ut Southwestern Medical Center

    Dallas, Texas, United States

  • University of Virginia Medical Center

    Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Jul 2017
Primary completion
25 Apr 2023
Completion
25 Apr 2023
Last update posted
10 Jul 2024
Registered enrollment
54
Registry id
NCT03028350

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.